← All decks

ENT

Local Drug Delivery to the Inner Ear

Built from Haynes-Glasscock-Shambaugh Surgery of the Ear, Seventh Edition

What’s inside

9 sections · 104 slides

  1. 01

    Overview

    • Scope of this topic

    1 slide

  2. 02

    Rationale for Local Delivery

    • Two categories of inner ear drug delivery
    • Volume mismatch between body and perilymph
    • Anatomic connections of the inner ear
    • Anatomy of the internal ear
    • Systemic versus local therapy
    • Middle ear as a drug reservoir

    6 slides

  3. 03

    Transtympanic Delivery Technique

    • Route of administration through the drum
    • Anatomic basis of middle ear drug delivery
    • Local anaesthesia of the tympanic membrane
    • Phenol application and single-use applicators
    • Duration of patency of the myringotomy
    • Refinements of the myringotomy technique
    • Needle selection and injection volume
    • Injection technique and post-procedure care
    • Sequence of a transtympanic injection

    9 slides

  4. 04

    Anatomic Considerations for Entry

    • Routes of diffusion into the inner ear
    • Three-layered structure of the round window membrane
    • Factors determining round window permeability
    • Obstruction of the round window niche
    • Anatomical variation and human pharmacokinetic data
    • Orientation of the round window in the upright patient
    • Strategies to improve round window transfer
    • Predicting permeability from molecular properties
    • Carrier systems for round window delivery

    9 slides

  5. 05

    Distribution and Clearance in Perilymph

    • Modelling distribution of medication in the inner ear
    • Absorption through the otic capsule
    • The stapediovestibular ligament as a delivery route
    • Passive diffusion within the scala tympani
    • Cochlear duct in cross section
    • Molecular weight and apical penetration
    • Elimination of drug from the cochlea
    • Devices to prolong round window contact

    8 slides

  6. 06

    Intrascalar Therapy

    • Rationale for direct intrascalar injection
    • Evidence that the inner ear tolerates instrumentation
    • The endolymphatic sac as a delivery site
    • Human gadolinium data from the endolymphatic sac
    • Cochlear implant candidates as a study population
    • Drug delivery channels within the electrode array
    • Cochlear implant components
    • Catheter-based intrascalar delivery in humans
    • Novel drug delivery devices for use in the ear
    • The reciprocating pump concept
    • Indications and risks of long-term pump delivery

    11 slides

  7. 07

    Medications in Current Clinical Use

    • Agents delivered locally to the inner ear
    • Streptomycin and the origins of ablative therapy
    • Evolution of intratympanic gentamicin protocols
    • Current gentamicin dosing and pre-treatment assessment
    • Indications for intratympanic steroids
    • Steroids in Meniere's disease
    • Improving dexamethasone availability at the membrane
    • Thermosensitive polymer steroid formulations
    • Intratympanic steroids in sudden hearing loss
    • Comparative evidence for the intratympanic route
    • Limitations of the steroid meta-analyses
    • Steroids in cochlear implantation
    • Preoperative steroids and unresolved timing
    • Cochlear NMDA receptors and tinnitus
    • Hyaluronic acid gel formulation of NMDA blockers
    • Apoptosis modulation in noise and ototoxic injury
    • Human data on the Jnk inhibitor AM 111
    • Antioxidants for ototoxicity and noise trauma
    • Trade-offs of local otoprotection during chemotherapy

    19 slides

  8. 08

    The Future of Inner Ear Delivery

    • Why biologics require direct intrascalar delivery
    • Rationale for inner ear gene therapy
    • Atoh1 and the specification of hair cells
    • Human vector administration and current trials
    • Spiral ganglion degeneration after deafness
    • Neurotrophin-3 and functional recovery
    • Delivery options for neurotrophic factors
    • Nanoparticles and hydrogels as delivery vehicles
    • Magnetic nanoparticle targeting
    • Cell transplantation to the inner ear
    • Embryonic transplantation and connexin 30 deficiency
    • Autologous versus allogeneic cell sources
    • Mesenchymal stromal cells and the secretome
    • Extracellular vesicles as next-generation cell therapy

    14 slides

  9. 09

    Summary

    • Established practice today
    • Principal limitations of middle ear delivery
    • Instrumentation needed for future delivery
    • Direction of travel for inner ear therapeutics
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Haynes-Glasscock-Shambaugh Surgery of the Ear, Seventh Edition
    • Join our WhatsApp groups

    19 slides